Survival and trends of occurrence of left ventricular hypertrophy, gender differences, 1967-92: The Reykjavik Study

Journal of Internal Medicine

Volumn 253, Issue 4, 2003, Pages 418-424

  Thrainsdottir, Inga S ^a,c   Hardarson, Th ^b   Thorgeirsson, G ^a,b   Sigvaldason, H ^a   Sigfusson, N ^a  

^a Heart Preventive Clinic Reykjavik   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Epidemiology; Gender differences; Left ventricular hypertrophy; Risk factors

Indexed keywords

ADULT; AGE; AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAM; FEMALE; GENDER; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SILENT MYOCARDIAL INFARCTION; STATISTICAL SIGNIFICANCE; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED; COHORT STUDIES; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; ICELAND; INCIDENCE; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 0345701219     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2003.01111.x     Document Type: Article

References (31)

1. Douglas PS, Katz SE, Weinberg EO et al. Hypertrophic remodelling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol 1998; 32: 1118-25.
2. Verdecchia P, Schillaci G, Borgioni C et al. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol 1998; 31: 383-90.
3. Aronow WS, Kronzon I, Koenigsberg M. Congestive heart failure, coronary events and atherothrombotic brain in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy. Am J Cardiol 1991; 67: 295-9.
4. Thrainsdottir IS, Hardarson Th, Thorgeirsson G, Sigvaldason H, Sigfusson N. The epidemiology of right bundle branch block and its association with cardiovascular morbidity - The Reykjavik Study. Eur Heart J 1993; 14: 1590-6.
5. Björnsson OJ, Davidsson D, Ólafsson Ó, Sigfusson N, Thorsteinsson Th. Report ABC XVIII. Health Survey in the Reykjavik Area. Males. Stages I-II, 1967-8, 1970-71 and 1974-76. Participants, Invitations, Responses etc. Reykjavik: Hjartavernd 1979.
6. Björnsson G. Björnsson OJ, Davidsson D et al. Report abc XXIV. Health Survey, in the Reykjavik Area. Women. Stages I-III, 1968-69, 1971-72 and 1976-78. Participants, Invitations etc. Reykjavik: Hjartavernd, 1982.
7. Rose GA, Blackburn H. Cardiovascular Survey Methods Geneva: World Health Organization, 1968.
8. WHO MONICA Project. MONICA Manual, revised edition. Geneva: Cardiovascular diseases unit, WHO, 1990.
9. Sigurdsson E, Thorgeirsson G, Sigvaldason H, Sigfusson N. Prevalence of coronary heart disease in Icelandic men in 1968-86. The Reykjavik Study. Eur Heart J 1993; 14: 584-91.
10. Jónsdóttir LS, Sigfusson N, Sigvaldason H, Thorgeirsson G. Incidence and prevalence of recognised and unrecognised myocardial infarction in women. The Reykjavik Study. Eur Heart J 1998; 19: 1011-8.
11. Gebsky V, Leung O, McNeil D, Lunn D. Statistical Package for Interactive Data Analysis (SPIDA), Version 6, Statistical Computing Lab 1992. Macquarie University, Sydney, Australia.
12. Ho KKL, Pinsky JL, Kannel WB, Levy DD. The epidemiology of heart failure: The Framingham study. J Am Coll Cardiol 1993; 22 (Suppl. A): 6A-13A.
13. Mostered A, D'Agostino RB, Silbershatz H et al. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Eng J Med 1999; 340: 1279-80.
14. Rigatto C, Foley RN, Kent GM, Guttman R, Parley PS. Long-term changes in left ventricular hypertrophy after renal transplantation. Transplantation. 2000; 20: 570-5.
15. Khattar RS, Senior R, Swales JD, Lahiri A. Value of ambulatory intraarterial blood pressure monitoring in the long term prediction of left ventricular hypertrophy and carotid atherosclerosis in essential hypertension. J Hum Hypertens 1999; 13: 111-6.
16. Kannel WB. Contribution of the Framingham Study to preventive cardiology. J Am Coll Cardiol 1990; 15: 206-11.
17. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991; 121 (3 Pt 1): 951-7.
18. DiBianco R. The changing syndrome of heart failure: an annotated review as we approach the 21st century. J Hypertension 1994; 12 (Suppl. 4): S73-S87.
19. Agabiti Rosei E, Muiesan ML. Left ventricular hypertrophy: how to influence an important risk factor in hypertension. J Hypertension 1998; 16 (Suppl. 1): S53-S58.
20. Schmieder RE, Schlach MP, Klingbeil AU, Martus P. Update on reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of all randomised double-blind studies until December 1996. Nephrol Dial Transpl 1998; 13: 564-9.
21. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-52.
22. Sloan PJM, Beevers DG. Hypertension and the heart. A review. Eur Heart J 1983; 4: 215-22.
23. Levy D, Andersson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988; 108: 7-13.
24. Franz IW, Tönnesmann U, Muller JFMU. Time course of complete normalisation of left ventricular hypertrophy during long term antihypertensive therapy with angiotensin converting-enzyme inhibitors. Am J Hypert 1998; 11: 631-9.
25. Casale PN, Devereux RB, Milner M et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-8.
26. Okin PM, Roman MJ, Devereux RB, Kligfield P. Gender differences and the electrocardiogram in left ventricular hypertrophy. Hypertension 1995; 25: 242-9.
27. Okin PM, Roman MJ, Devereux RB, Picketing TG, Borer JS, Kligfield P. Time voltage QRS area of the 12-lead electrocardiogram. Detection of left ventricular hypertrophy. Hypertension 1998; 31: 937-42.
28. Yamashita S, Dohi Y, Miyagawa K, Kojima M, Sato K. Reliability of the electrocardiogram for detecting left ventricular hypertrophy in the elderly. Am J Cardiol 1998; 81: 650-2.
29. Kannel W, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence and mortality in the Framingham Study. Ann Intern Med 1969; 71: 89-105.
30. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy associated with increased risk for sudden death. J Am Coll Cardiol 1998; 32: 1454-9.
31. Aronow WS, Epstein S, Koenigsberg M, Schwartz KS. Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients. Am J Cardiol 1988; 62: 124-5.